AYVAKYT 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
AYVAKYT 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Commercialized
Register Number
1201473004
Prescription Type
Diagnóstico Hospitalario
Authorization Date
May 26, 2022
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1201473004
EMA Approved
Yes
Drug Classification
✗
Generic
No
✓
Orphan
Yes
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
AVAPRITINIBActive
Quantity: 25 mg
Name: AVAPRITINIB
ATC CLASSIFICATION (3)
L01E
L01EX
L01EX18